(Q36307314)

13 August 2017

1 reference

title

Statins and cognition: what can we learn from existing randomized trials? (English)

1 reference

13 August 2017

Glen L Xiong

1

1 reference

PubMed ID

16273014

13 August 2017

Aaron Benson

series ordinal

2

1 reference

PubMed ID

16273014

13 August 2017

P Murali Doraiswamy

series ordinal

3

1 reference

13 August 2017

1 November 2005

1 reference

13 August 2017

1 reference

13 August 2017

10

1 reference

13 August 2017

11

1 reference

13 August 2017

867-874

1 reference

Statin-associated memory loss: analysis of 60 case reports and review of the literature

13 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Effects of lovastatin on cognitive function and psychological well-being

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performance

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Do low cholesterol levels slow mental processing?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Serum cholesterol concentrations are associated with visuomotor speed in men: findings from the third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Can altering serum cholesterol affect neurologic function?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Statin Use and the Risk of Incident Dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Randomized trial of the effects of cholesterol-lowering dietary treatment on psychological function.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Simvastatin-associated memory loss

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Serum lipoprotein levels, statin use, and cognitive function in older women

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and Simvastatin

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Effects of lovastatin and pravastatin on sleep efficiency and sleep stages

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

The role of cholesterol in the biosynthesis of beta-amyloid

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Inflammation and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Inhibitors of hydroxymethylglutaryl coenzyme A reductase for treating hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Enhanced oxidizability of ubiquinol and alpha-tocopherol during lovastatin treatment.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Pravastatin and lovastatin in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Serum lipids and memory in a population based cohort of middle age women

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Effects of treatment with lovastatin and pravastatin on daytime cognitive performance.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

The role of lipid-lowering drugs in cognitive function: a meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Statin use and hippocampal volumes in elderly subjects at risk for Alzheimer's disease: a pilot observational study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

A Position Paper: Based on Observational Data Indicating an Increased Rate of Altered Blood Chemistry Requiring Withdrawal from the Alzheimer's Disease Cholesterol-Lowering Treatment Trial (ADCLT)

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

Link between heart disease, cholesterol, and Alzheimer's disease: a review

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900019817

7 January 2021

10.1017/S1092852900019817

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16273014